RARX

Ra Pharmaceuticals, Inc. Common Stock
RARX

Overview Fund Activity
Delisted

RARX was delisted on the 1st of April, 2020.

Back to rankings

59 hedge funds and large institutions have $214M invested in Ra Pharmaceuticals, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 59 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
59
Holders Change
+59
Holders Change %
–
% of All Funds
1.48%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
%
% of All Funds
0.13%
New
59
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
NMC
NEA Management Company
Maryland
$53.1M
2
NHAS
Novo Holdings A/S
Denmark
$30.9M
3
Wellington Management Group
Wellington Management Group
Massachusetts
$23.9M
4
RCM
RA Capital Management
Massachusetts
$20.5M
5
RSCM
Rock Springs Capital Management
Maryland
$12.5M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Shares
Change %
SO
51
STRS Ohio
Ohio
$39K +$39K +2,600 New
UBS Group
52
UBS Group
Switzerland
$36K +$36K +2,391 New
Manulife (Manufacturers Life Insurance)
53
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$34K +$34K +2,220 New
Legal & General Group
54
Legal & General Group
United Kingdom
$19K +$19K +1,245 New
BJ
55
BlackRock Japan
Japan
$15K +$15K +984 New
FPFS
56
First Personal Financial Services
North Carolina
$9K +$9K +607 New
Royal Bank of Canada
57
Royal Bank of Canada
Ontario, Canada
$8K +$8K +495 New
TRCT
58
Tower Research Capital (TRC)
New York
$1K +$1K +68 New
1 2
3